Latest & greatest articles for pregnancy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pregnancy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pregnancy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pregnancy

81. Chronic renal diseases and pregnancy

Thrombosis prophylactic (LMWH) can be considered when proteinuria >5 g/d B 3 Renal transplant recipients Recommendations Level of evidence Recommendation Preconception Pregnancy should be postponed until: • > 1 year after kidney transplant • Pre-pregnant s-creatinine 110 bør vedligeholdelsesdosis med magnesiumsulfat halveres. Ved kreatinin>221 overvejes kun bolus Monitorering af de uræmisk metaboliske forhold, herunder hgb, D- vitamin, parathyroidea hormon, syre/base status mm. Der er risiko for blivende (...) . Klemetti MM, Laivuori H, Tikkanen M, Nuutila M, Hiilesmaa V, Teramo K. Obstetric and perinatal outcome in type 1 diabetes patients with diabetic nephropathy during 1988-2011. Diabetologia. 2015;58(4):678-686. 3. Damm JA, Asbjornsdottir B, Callesen NF, et al. Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: Prevalence, antihypertensive strategy, and pregnancy outcome. Diabetes Care. 2013;36(11):3489-3494. 4. Jensen DM, Korsholm L, Ovesen P, et al. Peri

2019 Nordic Federation of Societies of Obstetrics and Gynecology

82. Urological diseases and pregnancy

of the pregnant woman is ultrasound, then MR and finally imaging with radiation such as CT. 3 C DSOG 2019 Urology and pregnancy Page 3 of 3 Danish version Below you find the entire Danish version of the guideline Urologiske nyresygdomme og graviditet Guidelinen er en revision af tidligere Nyresygdomme og graviditet fra 2011. Denne guideline er delt op i 2: medicinske nyresygdomme og graviditet samt urologiske sygdomme og graviditet Forfattere: Al-Saudi Noor Introlæge Slagelse Eskildsen Morten Reservelæge (...) of pregnancy: Adv Biomed Res. 2016; 5: 186. 9. Stehman-Breen, C.O., et al., Increased risk of preeclampsia among nulliparous pregnant women with idiopathic hematuria. Am J Obstet Gynecol, 2002. 187(3): p. 703-8. 10. Tapp, D.C. and J.B. Copley, Effect of red blood cell lysis on protein quantitation in hematuric states. Am J Nephrol, 1988. 8(3): p. 190-3. Billeddiagnostiske undersøgelser af den gravide kvinde. Såfremt en undersøgelse er indiceret, skal den udføres. Der er formentlig større risiko

2019 Nordic Federation of Societies of Obstetrics and Gynecology

83. Tobacco and pregnancy

Tobacco and pregnancy 0 Tobacco and pregnancy A national guideline from the Danish Society of Obstetrics and Gynaecology Aims • To describe the risks of adverse fetal outcomes if a pregnant woman uses tobacco products. • To describe the risks of adverse outcomes among newborn children whose mothers use tobacco products during lactation. • To suggest a strategy for screening pregnant women for use of tobacco products. • To suggest a strategy for handling women who use tobacco products during (...) pregnancy and lactation. This guideline does not deal with social aspects related to the use of tobacco products by pregnant women or their partners, and it does not deal with tobacco products as markers of use of other drugs. Recommendations Evidence level Active and passive smoking, e-cigarettes and smokeless tobacco is discouraged during pregnancy. A/B All pregnant women should be asked about smoking status, exposure to passive smoking, use of e-cigarettes and smokeless tobacco at their first contact

2019 Nordic Federation of Societies of Obstetrics and Gynecology

84. Group B streptococci during pregnancy

søgningen: Allen VM, Yudin MH, Bouchard C, Boucher M, Caddy S, Castillo E, et al.; Infectious Diseases Committee, Society of Obstetricians and Gynaecologists of Canada. Management of group B streptococcal bacteriuria in pregnancy. J Obstet Gynaecol Can 2012; 34:482–6 Referencer fra Uptodate: Karen M Puopolo, Lawrence C Madoff. Group B streptococcal infection in pregnant women. Uptodate last updated july 15, 2017 Søgt på Cochrane med følgende søgeord : asymtomatic bacteriurina in pregnancy Samt søgt (...) ]) AND ("pregnancy"[MeSH Terms] OR "pregnancy"[All Fields])) AND ("association"[MeSH Terms] OR "association"[All Fields])) AND (Clinical Trial[ptyp] AND "2008/11/29"[PDat] : "2018/11/26"[PDat] AND "humans"[MeSH Terms] AND English[lang]) Søgningen gav 2 artikler, hvoraf 1 relevant Vaccination Søgestreng Medline Udført (05.11.2018)(flyttes) (((((Pregnancy[Title/Abstract]) OR Pregnancy[MeSH Terms]) OR Pregnant[Title/Abstract])) AND (((((((Vaccine[Title/Abstract]) OR Vaccination[MeSH Terms]) OR Vaccination[Title

2019 Nordic Federation of Societies of Obstetrics and Gynecology

85. SMFM Special Statement, research to knowledge: promoting the training of physician-scientists in the biology of pregnancy

SMFM Special Statement, research to knowledge: promoting the training of physician-scientists in the biology of pregnancy Research to knowledge: promoting the training of physician-scientists in the biology of pregnancy - American Journal of Obstetrics & Gynecology Email/Username: Password: Remember me Search Terms Search within Search Share this page: Volume 218, Issue 1, Pages B9–B13 To read this article in full, please review your options for gaining access at the bottom of the page (...) . Research to knowledge: promoting the training of physician-scientists in the biology of pregnancy Society for Maternal-Fetal Medicine (SMFM) , x Yoel Sadovsky Affiliations Magee-Womens Research Institute, University of Pittsburgh Department of Obstetrics, Gynecology and Reproductive Sciences, Pittsburgh, Pennsylvania, USA , MD a , x Aaron B. Caughey Affiliations Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA , MD, PhD b , x Michelle DiVito

2019 Society for Maternal-Fetal Medicine

86. Viral rash in pregnancy

Viral rash in pregnancy Viral rash in pregnancy - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Viral rash in pregnancy Information on the investigation, diagnosis and management of a pregnant woman who has, or is exposed to, viral rash illness. Published 1 January 2011 Last updated 22 July 2019 — From: Documents Ref: PHE publications gateway number GW-231 If you use assistive technology (...) covers rash illnesses caused by parvovirus B19 ( Telephone: 0300 123 1002 Copies of most printed publications can now be ordered online. Login to register and place your order. contains additional information. Published 1 January 2011 Last updated 22 July 2019 22 July 2019 Added new quick reference guide for health professionals. 21 March 2019 Updated 'Investigation, diagnosis and management of exposure to viral rash illness in pregnancy' document. 1 February 2016 Added link to information on Zika

2019 Public Health England

87. Vitamin D supplementation for women during pregnancy. Full Text available with Trip Pro

involving 3725 pregnant women were included in this comparison; 19 trials were assessed as having low-to-moderate risk of bias for most domains and three trials were assessed as having high risk of bias for most domains. Supplementation with vitamin D alone during pregnancy probably reduces the risk of pre-eclampsia (risk ratio (RR) 0.48, 95% confidence interval (CI) 0.30 to 0.79; 4 trials, 499 women, moderate-certainty evidence) and gestational diabetes (RR 0.51, 95% CI 0.27 to 0.97; 4 trials, 446 (...) for maternal adverse events, no firm conclusions can be drawn.Supplementation with vitamin D and calcium versus placebo/no interventionNine trials involving 1916 pregnant women were included in this comparison; three trials were assessed as having low risk of bias for allocation and blinding, four trials were assessed as having high risk of bias and two had some components having a low risk, high risk, or unclear risk. Supplementation with vitamin D and calcium during pregnancy probably reduces the risk

2019 Cochrane Controlled trial quality: predicted high

88. Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement. Full Text available with Trip Pro

Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement. Screening for hepatitis B virus (HBV) infection during pregnancy identifies women whose infants are at risk of perinatal transmission. Data from a nationally representative sample showed a prevalence of maternal HBV infection of 85.8 cases per 100 000 deliveries from 1998 to 2011 (0.09% of live-born singleton deliveries in the United States). Although (...) there are guidelines for universal infant HBV vaccination, rates of maternal HBV infection have increased annually by 5.5% since 1998. Children infected with HBV during infancy or childhood are more likely to develop chronic infection. Chronic HBV infection increases long-term morbidity and mortality by predisposing infected persons to cirrhosis of the liver and liver cancer.To update the 2009 US Preventive Services Task Force (USPSTF) recommendation on screening for HBV infection in pregnant women.The USPSTF

2019 JAMA

89. Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study. Full Text available with Trip Pro

Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study. To determine whether any association exists between exposure to 2009 pandemic H1N1 (pH1N1) influenza vaccination during pregnancy and negative health outcomes in early childhood.Retrospective cohort study.Population based birth registry linked with health administrative databases in the province of Ontario, Canada.All live births from November (...) hazard ratio 1.05, 95% confidence interval 1.02 to 1.09) and decreased rates of gastrointestinal infections (adjusted incidence rate ratio 0.94, 0.91 to 0.98). These results were unchanged in sensitivity analyses accounting for any potential differential healthcare seeking behavior or access between exposure groups.No associations were observed between exposure to pH1N1 influenza vaccine during pregnancy and most five year pediatric health outcomes. Residual confounding may explain the small

2019 BMJ

90. Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy. Full Text available with Trip Pro

bile acid profile, composed of primary or secondary, conjugated or non-conjugated bile acids, may provide more specific disease information.To assess and compare, independently or in combination, the diagnostic accuracy of total serum bile acids or serum bile acids profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy in pregnant women, presenting with pruritus. To define the optimal cut-off values for components of serum bile acid profile; to investigate possible sources (...) ), ProQuest Dissertations & Thesis Database, and Index to Theses in Great Britain and Ireland.Prospective or retrospective diagnostic case-control or cross-sectional studies, irrespective of publication date, format, and language, which evaluated the diagnostic accuracy of total serum bile acids (TSBA) or components of serum bile acid profile for the diagnosis of intrahepatic cholestasis of pregnancy in pregnant women of any age or ethnicity, in any clinical setting, symptomatic for pruritus.We selected

2019 Cochrane

91. Pregnancy and early life: reducing stillbirth and infant death

Pregnancy and early life: reducing stillbirth and infant death Pregnancy and early life: reducing stillbirth and infant death - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Pregnancy and early life: reducing stillbirth and infant death A planning tool to examine factors that influence stillbirth and infant death at the population level, rather than in individual clinical care. Published 12 March 2019

2019 Public Health England

92. Doxylamine/pyridoxine (Xonvea) for treating nausea and vomiting of pregnancy

at days 3, 4, 5 and 15. The MHRA concluded that the improvements are clinically important for women suffering from nausea and vomiting of pregnancy. The supporting study (the DESI study reported by Zhang et al. 2017) also found that, overall, doxylamine/pyridoxine improved symptoms of nausea and vomiting compared with placebo. Extensive data suggest that doxylamine/pyridoxine is safe for pregnant women to use, and that it is © NICE 2019. All rights reserved. Subject to Notice of rights (https (...) , which should be discussed with pregnant women before they are prescribed. Some prescribers and women may prefer doxylamine/pyridoxine because it is specifically licensed for use in pregnant women. Factors for decision making Factors for decision making Effectiveness Symptoms of nausea and v Symptoms of nausea and vomiting omiting At day 15, Koren et al. (2010) found a small but statistically significant improvement in the mean Pregnancy unique quantification of emesis (PUQE) symptom score (a measure

2019 National Institute for Health and Clinical Excellence - Advice

93. Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-beta-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the Euro (Abstract)

Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-beta-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the Euro In our randomized controlled trial, we investigated the impact of healthy eating (HE) aiming for restricted gestational weight gain (GWG) and physical activity (PA) interventions on maternal and neonatal lipid metabolism.Obese pregnant women (...) of pregnancy and neonatal outcomes were analyzed using general linear models with adjustment for relevant parameters.At 24-28 weeks' gestation, FFAs (mean ± SD, 0.60 ± 0.19 vs. 0.55 ± 0.17 mmol/L, P < 0.01) were increased after adjustment for FFA at baseline, maternal age, BMI at time of examination, gestational week, insulin resistance, self-reported food intake, self-reported physical activity, and maternal smoking, and GWG was lower (3.3 ± 2.6 vs. 4.3 ± 2.8 kg, P < 0.001, adjusted mean differences -1.0

2019 EvidenceUpdates

94. Cervical pessary for preventing preterm birth in twin pregnancies with maternal short cervix after an episode of threatened preterm labor: randomised controlled trial (Abstract)

pregnancies and a short cervix remaining after a threatened preterm labor episode.This open, randomized, controlled trial was conducted in 132 pregnant women who had not delivered 48 hours after a threatened preterm labor episode and had a short cervix remaining (≤20 mm between 240 and 296 weeks and ≤10 mm between 300 and 336 weeks). Patients were randomly assigned to cervical pessary (n = 67) or routine management (n = 65). The primary outcome was the spontaneous preterm birth rate before 34 weeks (...) Cervical pessary for preventing preterm birth in twin pregnancies with maternal short cervix after an episode of threatened preterm labor: randomised controlled trial No intervention has proved effective to date in reducing the spontaneous preterm birth rate in twin pregnancies following an episode of threatened preterm labor and with a short cervix remaining. This study was designed to ascertain whether cervical pessaries are useful in preventing spontaneous preterm birth in women with twin

2019 EvidenceUpdates

95. Hypertension in pregnancy: diagnosis and management

Reducing the risk of hypertensive disorders in pregnancy Symptoms of pre-eclampsia Symptoms of pre-eclampsia 1.1.1 Advise pregnant women to see a healthcare professional immediately if they experience symptoms of pre-eclampsia. Symptoms include: severe headache problems with vision, such as blurring or flashing before the eyes severe pain just below the ribs vomiting sudden swelling of the face, hands or feet. See the NICE guideline on antenatal care for advice on risk factors and symptoms of pre (...) -eclampsia. [2010, amended 2019] [2010, amended 2019] Antiplatelet agents Antiplatelet agents 1.1.2 Advise pregnant women at high risk of pre-eclampsia to take 75–150 mg of aspirin [1] daily from 12 weeks until the birth of the baby. Women at high risk are those with any of the following: hypertensive disease during a previous pregnancy chronic kidney disease autoimmune disease such as systemic lupus erythematosus or antiphospholipid Hypertension in pregnancy: diagnosis and management (NG133) © NICE 2019

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

96. Oral retinoid medicines: revised and simplified pregnancy prevention educational materials for healthcare professionals and women

Oral retinoid medicines: revised and simplified pregnancy prevention educational materials for healthcare professionals and women Oral retinoid medicines▼: revised and simplified pregnancy prevention educational materials for healthcare professionals and women - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Oral retinoid medicines▼: revised and simplified pregnancy prevention educational materials for healthcare (...) professionals and women New prescriber checklists, patient reminder cards, and pharmacy checklists are available to support the Pregnancy Prevention Programme in women taking acitretin, alitretinoin, and isotretinoin. Advice about the risk of neuropsychiatric reactions has been made consistent for all oral retinoid medicines. Published 19 June 2019 From: Therapeutic area: , , , , , Contents Advice for healthcare professionals about teratogenicity: following a detailed review, educational materials

2019 MHRA Drug Safety Update

97. Self-reported Physical Health of Women Who Did and Did Not Terminate Pregnancy After Seeking Abortion Services: A Cohort Study. (Abstract)

Self-reported Physical Health of Women Who Did and Did Not Terminate Pregnancy After Seeking Abortion Services: A Cohort Study. Research demonstrates worse short-term morbidity and mortality associated with childbirth than with abortion, but little research has examined long-term physical health in women with unwanted pregnancies after abortion versus childbirth.To examine the physical health of women who seek and receive or are denied abortion.Prospective cohort study.30 U.S. abortion

2019 Annals of Internal Medicine

98. Association of Blood Donor Sex and Prior Pregnancy With Mortality Among Red Blood Cell Transfusion Recipients. Full Text available with Trip Pro

Association of Blood Donor Sex and Prior Pregnancy With Mortality Among Red Blood Cell Transfusion Recipients. Evidence regarding associations of blood donor sex with mortality among red blood cell transfusion recipients is conflicting.To study associations of donor sex and prior pregnancy with mortality of transfusion recipients.Data from 3 retrospective cohorts of transfusion recipients (the Kaiser Permanente Northern California [KPNC] and Recipient Epidemiology and Donor Evaluation Study-III (...) transfusions.The number of transfused red blood cell units from female donors, previously pregnant donors, and sex-discordant donors (male donor and female recipient or female donor and male recipient).In-hospital mortality.The study population included 34 662 patients (mean age, 69 years; 18 652 [54%] women) from the KPNC cohort, 93 724 patients (mean age, 61 years; 48 348 [52%] women) from the REDS-III cohort, and 918 996 patients (mean age, 72 years; 522 239 [57%] women) from the SCANDAT cohort. The median

2019 JAMA

99. Diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (dTaP/IPV) for pregnant women: patient group direction (PGD) template

Diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (dTaP/IPV) for pregnant women: patient group direction (PGD) template application/vnd.openxmlformats-officedocument.wordprocessingml.document

2019 Public Health England

100. Viral rash in pregnancy

Epstein-Barr virus 13 2.2.8 Cytomegalovirus (CMV) 13 2.3 Advice and information on rash illness for pregnant women 14 3. A pregnant woman presenting with a rash illness 15 3.1 Laboratory investigation and management 15 3.2 Maculopapular rashes in pregnancy 16 3.2.1 Parvovirus 17 Laboratory investigation of suspected parvovirus B19 17 Management of confirmed parvovirus B19 17 Laboratory investigation of hydrops fetalis 18 Management of hydrops fetalis following confirmed parvovirus B19 18 3.2.2 Measles (...) on the investigation, diagnosis and management of viral rash illness, or exposure to viral rash illness, in pregnancy 4 4.2.2 VZIG restrictions for pregnant women during times of shortage 30 5. Other considerations for pregnant women 32 5.1 Occupational exposure 32 Parvovirus B19 32 Measles 32 Chickenpox 32 Rubella 32 5.2 Antibody screening 33 Parvovirus B19 33 Measles 33 Varicella 33 Rubella 33 5.3 Inadvertent immunisation during pregnancy 33 Table 1 35 References 37 Guidance on the investigation, diagnosis

2019 Public Health England